Jordan has built a career at the intersection of science, innovation, and business by bringing technical, technological, and business development support to advance successful companies in the biotechnology sector. Since joining Providence Therapeutics in 2018, Jordan has played a pivotal role in establishing the company’s mRNA platform and executing on its business development strategy. In his capacity as Partnerships and Innovation Director, he has led the negotiation and execution of many strategic partnerships, resulting in multiple collaborative programs and clinical trials with leading institutions worldwide. Jordan currently oversees the implementation of an innovative partnership strategy designed to place Providence’s proven mRNA platform in the hands of top oncology, infectious disease, and genetic therapy researchers, while managing a robust innovation pipeline for mRNA and LNP technologies.

Jordan holds both a Master’s and a PhD in Immunology, where his research focused on infectious diseases, and unraveling the many tricks that viruses use to avoid detection by the immune system.

Jordan is passionate about developing high-impact therapeutics, building great companies, and driving innovation in health.